Advertisement

Topics

Chi-Med’s ASCO data thrusts fruquintinib forward

08:40 EDT 6 Jun 2017 | thePharmaLetter

Hutchison China MediTech has announced results from its pivotal Phase III trial of fruquintinib, its…

Original Article: Chi-Med’s ASCO data thrusts fruquintinib forward

NEXT ARTICLE

More From BioPortfolio on "Chi-Med’s ASCO data thrusts fruquintinib forward"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...